Biogen, Inc. (BIIB)
175.58
+3.24
(+1.88%)
USD |
NASDAQ |
Apr 07, 16:00
177.10
+1.52
(+0.87%)
After-Hours: 19:26
Biogen Price : 175.58 for April 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 339.40 |
| Gilead Sciences, Inc. | 138.57 |
| Eli Lilly & Co. | 930.05 |
| Merck & Co., Inc. | 119.32 |
| Apellis Pharmaceuticals, Inc. | 40.69 |
Price Related Metrics
| PE Ratio | 19.38 |
| PS Ratio | 2.627 |
| Price to Book Value | 1.372 |
| Price to Free Cash Flow | 12.72 |
| Earnings Yield | 5.16% |
| Market Cap | 25.77B |
| Operating PE Ratio | 10.35 |
| Normalized PE Ratio | 14.63 |